In 2025, the Nasdaq‑100® celebrated its 40th anniversary, cementing its role as the world’s leading large‑cap growth index. With over $500B in exchange‑traded products and availability across six ...

A Singaporean initiative to boost the IPO market with a fast-track route to a Nasdaq dual listing has garnered a warm response from potential issuers, though bankers caution thin liquidity and a high ...

Chinese AI and semiconductor stocks have rallied since the breakout of the China-made DeepSeek-R1 AI model in January 2025.

Nasdaq once again led the U.S. listings market in 2025, welcoming the largest exchange transfer in history and the biggest IPO of the year. This year marked the exchange’s highest volume for capital ...

SpaceX has confirmed a target IPO date of 2026. The company may reach an IPO valuation of $1.5 trillion. At that price, SpaceX will sell for more than 60x current-year sales. Where to invest $1,000 ...

About This EventMedline Inc. (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, visits the Nasdaq MarketSite in Times Square to ...

Aktis Oncology, Inc. (NASDAQ: AKTS) IPO will take place January, 09 on the NASDAQ exchange under the ticker AKTS. The company ...

Renaissance IPO ETF (IPO) is rated a buy, anticipating a surge in major IPOs through 2026 to fuel renewed investor interest.

The year began with post-election optimism and expectations of a strong first quarter. Instead, markets were hit by the rise of low-cost AI initiatives from China, and its adverse impact on the U.S.

Lafayette Digital Acquisition Corp. I priced its initial public offering of 25 million units at $10.00 per unit, raising $250 million. The special purpose acquisition company structured as a Cayman ...

Capital market activity is rebounding as favorable market conditions encourage IPOs and M&A. The total deal value of mergers and acquisitions has surged, driven by major transactions, divestitures, ...